Hatteras Venture Partners

Investor type

VC

Founded

2000

AUM

$450 M

Location

Durham, North Carolina, United States

Investment Ticket

$1-5 m

Investment Stage

Series A Seed Series B

Region of investment

North America
Investor profile last updated: 31 August, 2026

Profile

Hatteras Venture Partners is a healthcare venture capital investor based in the Research Triangle. They focus on partnering with visionary founders to build transformative companies in biotech, Medtech, and Healthtech. With over 25 years of experience and a proven track record, they differentiate themselves through a health-centric focus and active partnership with their portfolio companies.

The firm invests broadly across the healthcare space, targeting sectors such as biotech, Medtech, and Healthtech. They emphasize early-stage investments and are committed to identifying high-quality science and teams with significant potential impact. Hatteras Venture Partners maintains a robust North American investment footprint, leveraging their extensive network to create multiple paths of optionality for their companies.

Notable investments include companies like Bioventus - orthopedic solutions, and others focused on innovative healthcare solutions. Hatteras Venture Partners aims to build transformational companies that benefit patients and healthcare professionals alike.

Industry

Biotechnology Consumer Services (B2C) Fashion/Beauty Financial Services Healthcare Services Medical Devices Other Pharmaceuticals MedTech Life Sciences HealthTech

Contacts

Name
Title
Email
avatar
Christy L Shaffer General Partner
General Partner
c•••@•••
avatar
Clay Thorp General Partner
General Partner
c•••@•••
Upgrade to see contacts
avatar
F30yH6bAqNr8vGCn F30yH6bAqNr8vGCn
F30yH6bAqNr8vGCn
avatar
F30yH6bAqNr8vGCn F30yH6bAqNr8vGCn
F30yH6bAqNr8vGCn
avatar
F30yH6bAqNr8vGCn F30yH6bAqNr8vGCn
F30yH6bAqNr8vGCn
Investment-team contacts for Hatteras Venture Partners — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Hatteras Venture Partners

Hatteras Venture Partners is a venture capital firm. It backs companies at Series A, Seed and Series B, writing tickets of $1-5 m.
Hatteras Venture Partners is located in Durham, North Carolina, United States.
Hatteras Venture Partners was founded in 2000.
Hatteras Venture Partners invests in companies and startups in Biotechnology, Consumer Services (B2C), Fashion/Beauty, Financial Services, Healthcare Services, Medical Devices, Other, Pharmaceuticals, MedTech, Life Sciences, HealthTech.
Hatteras Venture Partners invests in companies and startups in North America.
Hatteras Venture Partners invests in companies and startups at Series A, Seed, Series B.
Hatteras Venture Partners usually invests $1-5 m on average.
Hatteras Venture Partners has around $450m assets under management.
Hatteras Venture Partners can be reached through its website hatterasvp.com and its LinkedIn page. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Hatteras Venture Partners — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Hatteras Venture Partners directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 31 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.